The global impact of Precision Medicine Group.
As it happens.
Impact, observations, and insights on the evolving healthcare landscape.
We are excited to share that Carolyn Morgan, president of Precisioneffect, will be inducted into the MM&M Hall of Femme. This program honors honor standout U.S. healthcare commercial executives who have made a significant impact on their organization’s success in the past year.
ADDITION OF NATIVE ARTIFICIAL INTELLIGENCE CAPABILITY PROVIDES CLIENTS WITH INTUITIVE, INTERPRETABLE, AND INTERACTIVE BIOMARKER-BASED MODELS
Bethesda, MD – March 6, 2019 – Precision for Medicine, part of Precision Medicine Group, today announced the acquisition of SimplicityBio, adding artificial intelligence to Precision’s QuartzBio™ multiomic data integration and informatics platform. The addition of an artificial intelligence engine to QuartzBio provides Precision’s clients the most robust, sophisticated end-to-end solution for the “big data” challenge observed in biomarker-guided drug development—furthering their mission of maximizing the value and utility of biomarker data generated in the course of a clinical trial.
On Wednesday, September 26th at 10:00am PDT/1:00pm EDT please join us for a special, live webinar:
Navigating the FDA’s Final Guidance on HCEI and PIE:
Value Communication That Works
New announced research finds Epiontis ID™ technology can advance newborn screening as well as treatment of HIV patients in low-resource countries. (more…)
We are excited to announce that Precision Value & Health, a business unit of Precision Medicine Group, has been ranked #6 in MM&M magazine’s Agency Top 100 list! With a 10.6% increase in revenue from the previous year, they are continuing to add talent and services–partnering with pharmaceutical and life sciences companies to ensure patient access to life-changing therapies. (more…)
In an interview with KNect365, Precision Oncology’s Dr. Tandy Tipps, VP, Oncology Site Network, tells you how to match the right sites to the right trials and enable the opportunities of precision oncology trials. (more…)
In an article in Pharmaceutical Commerce, Precision’s Dominic Galante and Maureen Hennessey stress the importance of patient support services among pharma companies, payers, and providers. (more…)